Thinly traded Chembio Diagnostics (CEMI +4.2%) promptly erases a 1.6% decline after SA Pro...

|About: Chembio Diagnostics, Inc. (CEMI)|By:, SA News Editor

Thinly traded Chembio Diagnostics (CEMI +4.2%) promptly erases a 1.6% decline after SA Pro contributor Paul Nouri's article comes out of embargo. Nouri says the company could earn $0.45/share by 2015.